Showing results (11-20 of 101) with videos related to
Sort By:
Pageof 11
Seminars in Oncology|April 18, 2006
Richter's transformation in chronic lymphocytic leukemiaApostolia-Maria Tsimberidou, Michael J KeatingCancer|April 30, 2009
Treatment of fludarabine-refractory chronic lymphocytic leukemiaApostolia-Maria Tsimberidou, Michael J KeatingGenome Medicine|May 12, 2025
Patient rights in precision oncology: right treatment, right time, right dose, right order, right placeElena Fountzilas, Apostolia-Maria Tsimberidou, Razelle KurzrockExpert Opinion on Investigational Drugs|November 19, 2010
Farnesyltransferase inhibitors: where are we now?Apostolia Maria Tsimberidou, Chandtip Chandhasin, Razelle KurzrockExpert Review of Anticancer Therapy|March 22, 2003
Evolving role of ribonucleoside reductase inhibitors in hematologic malignanciesApostolia-Maria Tsimberidou, Yesid Alvarado, Francis J GilesPharmacology & Therapeutics|February 1, 2011
Common cardiovascular medications in cancer therapeuticsChristos Vaklavas, Yiannis S Chatzizisis, Apostolia Maria TsimberidouFuture Oncology (London, England)|June 10, 2010
Salirasib in the treatment of pancreatic cancerErnesto Bustinza-Linares, Razelle Kurzrock, Apostolia-Maria TsimberidouThe Oncologist|February 9, 2010
Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target?Christos Vaklavas, Daniel Lenihan, Razelle Kurzrock, et al.Current Hematologic Malignancy Reports|April 29, 2010
Richter's transformation in chronic lymphocytic leukemiaApostolia-Maria Tsimberidou, Michael J Keating, William G WierdaJournal of the American Academy of Dermatology|July 29, 2004
Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomasApostolia-Maria Tsimberidou, Francis J Giles, Madeleine Duvic, et al.Pageof 11